CRISPR-mediated Sox9 activation and RelA inhibition enhance cell therapy for osteoarthritis

Lan Zhao(Rush University Medical Center), Jian Huang(University of Rochester Medical Center), Ke Lu(Shenzhen Institute of Information Technology), Hongli Jiao(University of Wisconsin–Madison), Jun Li(Jiangnan University), Yumei Lai(Rush University Medical Center)
Molecular Therapy
June 14, 2024
10.1016/j.ymthe.2024.06.016
Cited by 20

Related Papers

Implant-derived magnesium induces local neuronal production of CGRP to improve bone-fracture healing in rats
|Nature Medicine|2016|1k
MicroRNA-204 Regulates Runx2 Protein Expression and Mesenchymal Progenitor Cell Differentiation
|Stem Cells|2009|611
Metformin limits osteoarthritis development and progression through activation of AMPK signalling
|Annals of the Rheumatic Diseases|2020|301
The F-Box Protein AhSLF-S<sub>2</sub> Controls the Pollen Function of S-RNase–Based Self-Incompatibility
|The Plant Cell|2004|239
The F-Box Protein AhSLF-S<sub>2</sub> Physically Interacts with S-RNases That May Be Inhibited by the Ubiquitin/26S Proteasome Pathway of Protein Degradation during Compatible Pollination in Antirrhinum
|The Plant Cell|2004|200